Literature DB >> 21193112

Platelet-derived microparticles - an updated perspective.

Pia R M Siljander1.   

Abstract

Platelet-derived microparticles (PMP) are a heterogeneous population of vesicles (< 1 mm) generated from the plasma membrane upon platelet activation by various stimuli. They are a discrete population differing from the exosomes which originate from the intracellular multivesicular bodies. PMP also differ from the microparticles derived from megakaryocytes despite the presence of several identical surface markers on the latter. The molecular properties and the functional roles of the PMP are beginning to be elucidated by the rapidly evolving research interest, but novel questions are simultaneously raised. This updated perspective discusses the most recent highlights in the PMP research in context with the methodological problems and the paradoxical role of the PMP in health and disease. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21193112     DOI: 10.1016/S0049-3848(10)70152-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  22 in total

1.  Oxidized low-density lipoprotein-dependent platelet-derived microvesicles trigger procoagulant effects and amplify oxidative stress.

Authors:  Hua Wang; Zhi-Hao Wang; Jing Kong; Meng-Yun Yang; Gui-Hua Jiang; Xu-Ping Wang; Ming Zhong; Yun Zhang; Jing-Ti Deng; Wei Zhang
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

Review 2.  Extracellular vesicles and atherosclerotic disease.

Authors:  Dimitry A Chistiakov; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Cell Mol Life Sci       Date:  2015-04-17       Impact factor: 9.261

3.  Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection.

Authors:  Nuntaya Punyadee; Dumrong Mairiang; Somchai Thiemmeca; Chulaluk Komoltri; Wirichada Pan-Ngum; Nusara Chomanee; Komgrid Charngkaew; Nattaya Tangthawornchaikul; Wannee Limpitikul; Sirijitt Vasanawathana; Prida Malasit; Panisadee Avirutnan
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

Review 4.  Circulating extracellular vesicles and rheumatoid arthritis: a proteomic analysis.

Authors:  Mohammed Alghamdi; Sultan Abdulmughni Alamry; Sami M Bahlas; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Cell Mol Life Sci       Date:  2021-12-31       Impact factor: 9.261

5.  Platelets are efficient and protective depots for storage, distribution, and delivery of lysosomal enzyme in mice with Hurler syndrome.

Authors:  Mei Dai; Jingfen Han; Salim S El-Amouri; Roscoe O Brady; Dao Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

6.  Thrombocytopenia Is Associated With Multi-organ System Failure in Patients With Acute Liver Failure.

Authors:  R Todd Stravitz; Caitlyn Ellerbe; Valerie Durkalski; Adrian Reuben; Ton Lisman; William M Lee
Journal:  Clin Gastroenterol Hepatol       Date:  2015-12-10       Impact factor: 11.382

Review 7.  Platelets and cancer: a casual or causal relationship: revisited.

Authors:  David G Menter; Stephanie C Tucker; Scott Kopetz; Anil K Sood; John D Crissman; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

Review 8.  The role of the myofibroblast in tumor stroma remodeling.

Authors:  Marcela Otranto; Vincent Sarrazy; Frédéric Bonté; Boris Hinz; Giulio Gabbiani; Alexis Desmoulière
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

Review 9.  Circulating microparticles: square the circle.

Authors:  Natasha S Barteneva; Elizaveta Fasler-Kan; Michael Bernimoulin; Joel N H Stern; Eugeny D Ponomarev; Larry Duckett; Ivan A Vorobjev
Journal:  BMC Cell Biol       Date:  2013-04-22       Impact factor: 4.241

10.  Activation induced morphological changes and integrin αIIbβ3 activity of living platelets.

Authors:  Sandra Posch; Isabel Neundlinger; Michael Leitner; Peter Siostrzonek; Simon Panzer; Peter Hinterdorfer; Andreas Ebner
Journal:  Methods       Date:  2013-04-06       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.